A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
Rachel M LeeAdriana C GamboaMichael K TurgeonMohammad Y ZaidiCharles KimbroughJennifer L LeitingTravis E GrotzAndrew J LeeKeith FournierBenjamin D PowersSean DineenJoel M BaumgartnerJula VeerapongHarveshp MogalCallisia N ClarkeGregory WilsonSameer H PatelRyan J HendrixLaura LambertCourtney PokrzywaDaniel E AbbottChristopher J LaRoccaMustafa RaoofJonathan GreerFabian M JohnstonCharles A StaleyJordan M CloydShishir K MaithelMaria C RussellPublished in: Journal of surgical oncology (2020)
As CRS/HIPEC + LR has become more common, we created a simple risk score to stratify patients considered for CRS/HIPEC + LR. These data aid in striking the balance between an increased perioperative complication profile with the potential for improvement in OS.